Applications invited in Production, Quality Control Department at Aspiro Pharma
5 March 2026

Applications invited in Production, Quality Control Department at Aspiro Pharma

Having Injectable Experience of Shop floor supervising activities like filtration, Filling, Sealing, Stoppering, Garment Washing, Vial Washing, Autoclave, Ophthalmic, Suspensions, Lyophilizes. Operations and Training and QMS.
USV hiring Quality Assurance professionals
5 March 2026
USV hiring Quality Assurance professionals
Validation professional with expertise in qualification / validation / re-qualification of instruments, equipment & utilities; hands-on validation through electronic systems; calibration & preventive maintenance.
Work as First Line Leader at GSK
5 March 2026
Work as First Line Leader at GSK
The First Line Leader is accountable for developing and enabling a frontline team of operators to consistently deliver exceptional safety, quality, service and cost‑effective products.
CDSCO Issues Alert After Theft of Sanofi Lantus Insulin Pens During Transit
5 March 2026
CDSCO Issues Alert After Theft of Sanofi Lantus Insulin Pens During Transit

India’s drug regulator has issued a public advisory after a consignment of insulin pens manufactured by Sanofi India Limited was reported stolen during transportation, raising concerns about potential risks if the products enter the market through unauthorized channels.

Moderna Settles Vaccine Patent Dispute with 950 Million USD Deal
5 March 2026
Moderna Settles Vaccine Patent Dispute with 950 Million USD Deal
Biotechnology company Moderna has announced a major settlement to resolve global patent litigation with Arbutus Biopharma Corporation and Genevant Sciences GmbH over technology used in its mRNA vaccines. The agreement settles all ongoing lawsuits worldwide related to the companies’ disputes.
Sanofi’s rilzabrutinib earns orphan drug designation in Japan for IgG4-related disease
5 March 2026
Sanofi’s rilzabrutinib earns orphan drug designation in Japan for IgG4-related disease
The Ministry of Health, Labour and Welfare (MHLW) in Japan has granted orphan drug designation to rilzabrutinib, a novel, oral, reversible covalent Bruton’s tyrosine kinase (BTK) inhibitor, for IgG4-related disease (IgG4-RD).
US FDA Approves Glenmark’s Generic Fluticasone Propionate Inhaler for Asthma Treatment
5 March 2026
US FDA Approves Glenmark’s Generic Fluticasone Propionate Inhaler for Asthma Treatment
Glenmark Specialty SA has received final approval from the U.S. Food and Drug Administration for Fluticasone Propionate Inhalation Aerosol USP
CDSCO Announces Faster NOC Process for Drug Testing Before Approval
5 March 2026
CDSCO Announces Faster NOC Process for Drug Testing Before Approval
The regulator has announced that companies will now receive the No Objection Certificate, NOC more quickly, helping to streamline regulatory procedures and reduce approval timelines.
Applications invited for Pharma candidates in Dr.R.P. Centre for Ophthalmic Sciences, AIIMS
4 March 2026
Applications invited for Pharma candidates in Dr.R.P. Centre for Ophthalmic Sciences, AIIMS
D.Pharm plus two Years experience in relevant subject/field. Managing Ocular Surface Disorders, Randomized Trials on Dry Eye Disease and Meibomian Gland Dysfunction
Join Regional Centre for Biotechnology - Opportunities for Life Sciences
4 March 2026
Join Regional Centre for Biotechnology - Opportunities for Life Sciences
M.Sc /M. Tech. in Life Sciences or related natural science disciplines. Lethal Aortopathy syndrome associated with novel FBLN4D203A Mutation among Mappila Children of Malabar, Kerala - seeking novel clinical, molecular genetic and anthropological insights.